Wei Cao

9PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisMolecular targetsCraniofacial biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 24, 2026
Single-Cell Profiling Reveals Stromal-Immune Remodeling in HNSCC After TPF-Based Neoadjuvant Chemotherapy.

|Nov 18, 2025
YY1 Induced FOXD2-AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2/CDKN1A Axis.

Zhonglin Yu, Xiaohu Lin, Pengfei Zhao

|Jul 28, 2025
Targeting Intratumoral Copper Inhibits Tumor Progression via p62-Mediated EZH2 Degradation and Potentiates Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinoma.

Xiaohu Lin, Wanling Chen, Bo Li

|Apr 02, 2025
The Application of Adjuvant Radiotherapy in pN1 OSCC Patients Without Adverse Pathologic Features.

Bo Li, Zhang Zhao, Yu Huang

|Jul 04, 2023
Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation.

Wenkai Zhou, Yisheng Feng, Chengzhong Lin

|Jan 03, 2023
Head-and-neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators.

Zhenlin Dai, Youya He, Xu Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Xiaohu Lin

2 joint publications

Chengzhong Lin

1 joint publications

Lei Wang

1 joint publications

Xiangjun Meng